The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Ventolin Evohaler 100 micrograms pressurised inhalation, suspension

100 microgram(s)/dose Pressurised inhalation, suspension

Lexon (UK) LtdPPA1097/054/001

Main Information

Trade NameVentolin Evohaler 100 micrograms pressurised inhalation, suspension
Active SubstancesSalbutamol
Strength100 microgram(s)/dose
Dosage FormPressurised inhalation, suspension
Licence HolderLexon (UK) Ltd
Licence NumberPPA1097/054/001

Group Information

ATC CodeR03AC Selective beta-2-adrenoreceptor agonists
R03AC02 salbutamol


Withdrawn Date31/08/2021
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0078-138-053
Interchangeable List DocumentPDF of Interchangeable List
« Back